2020 100+ 30+
Estabished Customers Intellectual property rights
keep In Touch
It has survived not only five centuries, but also the leap scra
—————————— ◉ ——————————
Grocellbio:Innovating the Future of Cell Thawing
Your Partner for Safe, Automated and Standardized Thawing
Clinical project using Grocellbio cell thawing devices in the process which were accepted or approved by the FDA
Established: August 2020, Shanghai, China
Mission: To independently research, develop, produce, and sell innovative biomedical instruments, enabling domestic substitution and global market expansion.
Expertise: Specializing in water-free, automated cell thawing devices and intelligent software.
About Grocellbio
Our Competitive Advantages
Unparalleled Safety: Multi-layered safety system with detachable heating module and emergency stop.
Automation & Integration: Seamless integration with SCADA and LIMS systems.
Regulatory Compliance: Software meets GLP and GMP requirements with full audit trail.
Proven Reliability: Validated by leading pharmaceutical companies.
|
Clinical Study |
ClinicalTrials.gov ID |
Drug Type |
FDA website link |
|
Phase I Clinical Study of BR105 Injection (BR105-I) |
NCT05351697 |
mAb |
https://clinicaltrials.gov/study/NCT05351697?term=BR105&rank=1 |
|
Comparative Study of BAT2206 With Stelara® in Patients With Moderate to Severe Plaque Psoriasis |
NCT04728360 |
Biosimilar
|
https://clinicaltrials.gov/study/NCT04728360?term=BAT2206&rank=2 |
|
Study to Compare the Efficacy and Safety of F-627 and GRAN |
NCT04174599 |
G-CSF |
https://clinicaltrials.gov/study/NCT04174599?term=evive&page=1&rank=2 |
|
SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas |
NCT06544720 |
CAR-T |
https://clinicaltrials.gov/study/NCT06544720?term=SCG142&rank=1 |
|
An Early Clinical Trial to Evaluate VGN-R09b for Treatment of Aromatic L-amino Acid Decarboxylase (AADC) Deficiency. |
NCT05765981 |
Gene Therapy |
https://clinicaltrials.gov/study/NCT05765981?term=VGN-R09b&rank=1 |
